Related Experiment Video

Updated: Jun 23, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

HLA complex and hypertrophic cardiomyopathy in a European population

J Beckers, R Vandeputte, J Geboers

    European Heart Journal
    |November 1, 1985
    PubMed

    Insights

    Human Leukocyte Antigen (HLA) antigen frequencies were similar in Belgian patients with hypertrophic cardiomyopathy (HCM) and healthy individuals. This suggests HLA type is not a significant risk factor for developing HCM in this population.

    Area of Science:

    • Immunogenetics
    • Cardiology
    • Human Leukocyte Antigen (HLA) System

    Background:

    • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition with potential genetic underpinnings.
    • The Human Leukocyte Antigen (HLA) system plays a crucial role in immune response and has been implicated in various diseases.
    • Understanding the genetic associations of HCM, including HLA antigen profiles, is vital for disease etiology research.

    Purpose of the Study:

    • To investigate the association between specific Human Leukocyte Antigen (HLA) antigen frequencies and hypertrophic cardiomyopathy (HCM) in a Belgian population.
    • To compare HLA antigen distributions in HCM patients with a control group of healthy individuals.

    Main Methods:

    • HLA tissue typing was conducted on 43 unrelated white individuals diagnosed with hypertrophic cardiomyopathy (HCM).
    • The study analyzed the frequency distribution of 14 HLA-A, 18 HLA-B, 5 HLA-C, and 10 HLA-D antigens.
    • Patient HLA antigen frequencies were compared against a control group of 800 healthy individuals from the same region.

    Main Results:

    • The frequency distribution of tested HLA-A, HLA-B, HLA-C, and HLA-D antigens showed no significant difference between HCM patients and the control group.
    • This similarity was observed across different subtypes of HCM, including obstructive, provocable obstructive, and non-obstructive forms.
    • No specific HLA antigen was found to be disproportionately represented in the HCM patient cohort compared to healthy controls.

    Conclusions:

    • The study indicates that Human Leukocyte Antigen (HLA) antigen profiles are unlikely to be a major genetic determinant for hypertrophic cardiomyopathy (HCM) in the studied white Belgian population.
    • These findings suggest that HLA tissue type does not confer a significant predisposition to developing HCM in this demographic.
    • Further research may explore other genetic or environmental factors contributing to HCM pathogenesis.

    More Related Videos

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    Related Concept Videos

    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...